Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice

Circulation

Volumn 92, Issue 9, 1995, Pages 2585-2593

  Ploplis, Victoria A ^a,b   Carmeliet, Peter ^a   Vazirzadeh, Shahrzad ^a,b   Van Vlaenderen, Ilse ^a   Moons, Lieve ^a   Plow, Edward F ^b   Collen, Désiré ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

fibrinolysis; genes; thrombolysis

Indexed keywords

FIBRIN; PLASMIN; PLASMINOGEN;

ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; FEMALE; FIBRIN DEPOSITION; FIBRINOLYSIS; GENE DISRUPTION; HEALTH STATUS; INHERITANCE; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; THROMBOSIS;

EID: 0028894880     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.92.9.2585     Document Type: Article

References (29)

1. Astrup T. Fibrinolysis: an overview. In: Davidson JF, Rowan RM, Samama MM, Desnoyers PC, eds. Progress in Chemical Fibrinolysis and Thrombolysis, Vol 3. New York, NY: Raven Press; 1978:1-57.
2. Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 1991;78:3114-3124.
3. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 1994;368:419-424.
4. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest. 1991;88:1067-1072.
5. Blasi F, Vassalli JD, Danø K. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol. 1987;104: 801-804.
6. Reich E. Activation of plasminogen: a general mechanism for producing localized extracellular proteolysis. In: Berlin RD, Heppman L, Lepow IH, Tanzer JM, eds. Molecular Basis of Biological Degradative Processes. New York, NY: Academic Press Inc; 1989:155-169.
7. Liu AC, Lawn RM. Lipoprotein (a) and atherogenesis. Trends Cardiovasc Med. 1994;4:40-44.
8. Carmeliet P, Kieckens L, Schoonjans L, Ream B, Van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D, Mulligan RC. Plasminogen activator inhibitor-1 gene-deficient mice, I: generation by homologous recombination and characterization. J Clin Invest. 1993;92:2746-2755.
9. Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Mulligan RC, Collen D. Plasminogen activator inhibitor-1 gene-deficient mice, II: effects on hemostasis, thrombosis and thrombolysis. J Clin Invest. 1993;92:2756-2760.
10. Dewerchin M, Carmeliet P, Van Nuffelen A, Collen D, Mulligan RC. Inactivation of the mouse urokinase receptor gene. Fibrinolysis. 1994;84(suppl 1):51. Abstract 142.
11. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 1991;65: 1153-1163.
12. Degen SJ, Bell SM, Schaefer LA, Elliot RW. Characterization of the cDNA coding for mouse plasminogen and localization of the gene to mouse chromosome 17. Genomics. 1990;8:49-61.
13. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol. 1985;87:27-45.
14. Bradley A. Production and analysis of chimeric mice. In: Robertson EJ, ed. Teratocarcinomas and Embryonic Stem Cells: A Practical Approach. Oxford, England: IRL Press; 1987:113-151.
15. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1989.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
17. Lijnen HR, Van Hoef B, Beelen V, Collen D. Characterization of the murine plasma fibrinolytic system. Eur J Biochem. 1994;224: 863-871.
18. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76: 4350-4354.
19. Mussoni L, Raczka E, Chmielewska J, Donati MB, Lattalo ZS. Plasminogen assay in rabbit, rat and mouse plasma using the chromogenic substrate S-2251. Thromb Res. 1979;15:341-349.
20. Stassen JM, Vanlinthout I, Lijnen HR, Collen D. A hamster pulmonary embolism model for the evaluation of the thrombolytic and pharmacokinetic properties of thrombolytic agents. Fibrinolysis. 1990;4(suppl 2):15-21.
21. Aoki N, Moroi M, Sakata Y, Yoshida N, Matsuda M. Abnormal plasminogen: a hereditary molecular abnormality found in a patient with recurrent thrombosis. J Clin Invest. 1978;61:1186-1195.
22. Huarte J, Belin D, Bosco D, Sappino AP, Vassalli JD. Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the germ cell surface. J Cell Biol. 1987;104:1281-1289.
23. Lala PK, Graham CH. Mechanisms of trophoblast invasiveness and their control: the role of proteases and protease inhibitors. Cancer Metastasis Rev. 1990;9:369-379.
24. Robbins KC. Dysplasminogenemias. Prog Cardiovasc Dis. 1992;34: 295-308.
25. 672 to Pro mutation. Blood. 1993;82:475-480.
26. Dolan G, Greaver M, Cooper P, Preston FE. Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds. Br J Haematol. 1988;70:417-421.
27. Plow EF. The major fibrinolytic proteases of human leukocytes. Biochim Biophys Acta. 1980;630:47-56.
28. Simon DI, Ezratty AM, Francis SA, Rehnke H, Loscalzo J. Fibrinogen is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): a nonplasmin fibrinolytic pathway. Blood. 1993;82:2414-2422.
29. Wakefield AJ, Dhillon AP, Rowler PM, Sawyer AM, Pittilo RM, Lewis AAM. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet. 1989;1057-1062.